| individual motion | Q96739634 |
| P953 | full work available at URL | http://data.riksdagen.se/dokument/H5021296 |
| http://data.riksdagen.se/dokumentstatus/H5021296 | ||
| P8433 | Swedish Riksdag document ID | H5021296 |
| P1001 | applies to jurisdiction | Sweden | Q34 |
| P50 | author | Margareta Gunsdotter | Q4961125 |
| P6216 | copyright status | public domain | Q19652 |
| P407 | language of work or name | Swedish | Q9027 |
| P1031 | legal citation of this text | Mot. 2017/18:1296 | |
| P7727 | legislative committee | Committee on Health and Welfare | Q10672943 |
| P921 | main subject | medication | Q12140 |
| Swedish Medical Products Agency | Q1879124 | ||
| P6104 | maintained by WikiProject | Project Riksdagen's documents | Q114364300 |
| P179 | part of the series | motions of 2017-2018 legislative session of the Riksdag | Q97722374 |
| P577 | publication date | 2017-10-03 | |
| P1476 | title | Läkemedelsverkets biverkningsregister |
| Q98408074 | Q98408074 | has immediate cause | P1478 |
Search more.